Group 1 - The stock of Zhejiang Sitaili Pharmaceutical Co., Ltd. increased by 5.01% on January 21, reaching a price of 11.11 CNY per share, with a trading volume of 150 million CNY and a turnover rate of 3.14%, resulting in a total market capitalization of 4.871 billion CNY [1] - The company, established on September 15, 1997, and listed on March 9, 2016, specializes in the production and sales of non-ionic iodine contrast agents and quinolone raw materials, with the main business revenue composition being 79.73% from contrast agents, 10.19% from other supplementary products, 6.16% from other sources, 2.41% from CMO/CDMO, and 1.52% from quinolone series [1] Group 2 - The Noan Theme Select Mixed Fund (320012) holds 720,100 shares of Sitaili, representing 4.53% of the fund's net value, making it the tenth largest holding. The estimated floating profit for today is approximately 381,600 CNY [2] - The Noan Theme Select Mixed Fund was established on September 15, 2010, with a current size of 173 million CNY. Year-to-date returns are 15.8%, ranking 225 out of 8,844 in its category, while the one-year return is 43.35%, ranking 2,504 out of 8,091. Since inception, the fund has achieved a return of 257.08% [2] Group 3 - The fund manager of the Noan Theme Select Mixed Fund is Luo Chunlei, who has been in the position for 10 years and 121 days. The total asset size of the fund is 173 million CNY, with the best return during the tenure being 130.62% and the worst return being 2.88% [3]

Group 1 - The stock of Zhejiang Sitaili Pharmaceutical Co., Ltd. increased by 5.04% on January 20, reaching a price of 10.84 CNY per share, with a trading volume of 85.33 million CNY and a turnover rate of 1.83%, resulting in a total market capitalization of 4.75 billion CNY [1] - The company, established on September 15, 1997, and listed on March 9, 2016, specializes in the production and sales of non-ionic iodine contrast agents and quinolone raw materials, with the main business revenue composition being 79.73% from contrast agents, 10.19% from other supplementary products, 6.16% from other sources, 2.41% from CMO/CDMO, and 1.52% from quinolone series [1] Group 2 - According to data from the top ten holdings of funds, one fund under Nuoan Fund holds a significant position in Sitaili, specifically the Nuoan Theme Selected Mixed Fund (320012), which held 720,100 shares in the third quarter, accounting for 4.53% of the fund's net value, ranking as the tenth largest holding [2] - The Nuoan Theme Selected Mixed Fund (320012), established on September 15, 2010, has a current size of 173 million CNY, with a year-to-date return of 16.87% and a one-year return of 45.31%, ranking 213 out of 8,846 and 2,545 out of 8,091 respectively [2] - The fund manager, Luo Chunlei, has been in position for 10 years and 120 days, with the fund's total asset size at 173 million CNY, achieving a best return of 127.25% and a worst return of 2.88% during the tenure [2]

Core Insights - Sanxin Medical (300453.SZ) released its semi-annual report for 2025, indicating that as of August 8, 2025, seven institutional investors held a total of 34.2278 million shares, representing 6.55% of the total share capital [1] - The institutional holding percentage increased by 1.00 percentage points compared to the previous quarter [1] Institutional Investors - The institutional investors include multiple products from Qianhai Life Insurance Co., Ltd. and two newly disclosed public funds: Dacheng Two-Year Open Mixed A and Nu'an Thematic Selected Mixed [1] - The total institutional holding percentage is now 6.55%, reflecting a notable increase [1] Public Funds - One public fund, Huian Asset Rotation Mixed A, increased its holdings compared to the previous period, while three public funds were not disclosed in the current report [1] - The newly disclosed public funds indicate a slight increase in interest from institutional investors [1] Insurance Capital - Two insurance capital entities increased their holdings, including products from Qianhai Life Insurance Co., Ltd., with an increase percentage of 0.2% [2]